Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
Pilot Study for Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
2 other identifiers
observational
126
1 country
1
Brief Summary
On the EAU (European Association of Urology) guidelines, the ulcer type bladder pain syndrome (BPS) should be treated with transurethral resection (TUR) or coagulation (TUC) of ulcer. But, Up to date, there was no study to compare the therapeutic efficacy of TUR with TUC in ulcer type BPS patients. We assume TUR have a more therapeutic effect than TUC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 15, 2013
CompletedFirst Posted
Study publicly available on registry
October 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 14, 2017
December 1, 2017
5.3 years
July 15, 2013
December 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence-free survival between TUC and TUR
Until 12 months after the last subject be enrolled
Secondary Outcomes (6)
The change of voiding dairy parameters(mean number of micturition,Urgency etc) after each treatment
1,3,6,9 and 12 months
The change of Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF)
1,3,6,9 and 12months.
The change of Global Response Assessment(GRA) score
1,3,6,9 and 12 months
The change of EQ-5D (EuroQOL five dimensions) Health Questionnaire score
1,3,6,9 and 12months
The change of Patient Global Assessment(PGA)
12months
- +1 more secondary outcomes
Study Arms (2)
Transurethral Coagulation (TUC)
This cohort patients will be managed with Transurethral Coagulation (TUC) of IC ulcer lesion
Transurethral Resection(TUR)
This cohort patients will be managed with transurethral resection(TUR) of IC ulcer lesion
Interventions
Eligibility Criteria
Patients will be enrolled diagnosed with bladder pain syndrome by ESSIC proposal.
You may qualify if:
- Male and female aged 18 yrs or greater
- Patients diagnosed with BPS(Bladder Pain Syndrome)
- Symptom persisted more than 6 months
- Pain VAS ≥4
- O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) scores 12 or greater with pain and nocturia domain scores \> 2.
- Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF) \>13
- No history of cystoscopy within 2yrs.
You may not qualify if:
- History of augmentation cystoplasty or previous transurethral coagulation/resection due to BPS
- Child-bearing potential, pregnant or nursing women.
- Mean voided volume lesser than 40ml or over than 400ml.
- Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
- Urinary tract infection during run-in periods.
- Genitourinary tuberculosis or bladder,urethral and prostate cancer
- Recurrent urinary tract infection
- History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate operation or treatment etc within 6months.
- Neurologic disease history of cerebral infarction,multiple sclerosis or parkinsonism etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 135-710, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor,MD,PhD
Study Record Dates
First Submitted
July 15, 2013
First Posted
October 17, 2013
Study Start
June 1, 2012
Primary Completion
October 1, 2017
Study Completion
December 1, 2017
Last Updated
December 14, 2017
Record last verified: 2017-12